Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801619 · ClinicalTrials.gov registry record
Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia
A clinical trial of Neonatal Hyperbilirubinemia, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 273
- Enrollment target
- 1
- Study location
NCT00801619: Completed study of Neonatal Hyperbilirubinemia, sponsored by Massachusetts General Hospital.
NCT00801619 is a study of Neonatal Hyperbilirubinemia that has completed, run by Massachusetts General Hospital. The registered enrollment target is 273 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00801619, a study of Neonatal Hyperbilirubinemia, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 273 participants
- Enrollment target
- 1
- Study location
Study Summary
We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test results to improve physician adherence to the guidelines and quality of care.
Primary Outcome
Adeherence to AAP clinical guidelines in treating neonatal hyperbilirubinemia
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2008-11 |
| Est. Completion | 2011-12 |
What the finished NCT00801619 record still lists
NCT00801619 is an observational study that tracks outcomes without assigning an intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Neonatal Hyperbilirubinemia appearing as the primary indexed condition, and to 0 interventions.
NCT00801619 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00801619 about?
NCT00801619 is a clinical study titled "Bilicurves: Using Information Technology to Improve the Management of Neonatal Hyperbilirubinemia". We will use information technology to integrate the 2004 American Academy of Pediatrics guidelines for management of neonatal hyperbilirubinemia with laboratory reporting of newborn bilirubin test results to improve physician adherence to the guidelines and quality of care.
What is the current status of trial NCT00801619?
This trial is currently completed. The enrollment target is 273 participants. The study started on 2008-11. Estimated completion is 2011-12.
What conditions does trial NCT00801619 study?
This clinical trial studies the following conditions: Neonatal Hyperbilirubinemia.
Who is sponsoring clinical trial NCT00801619?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801619 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia